Novartis AG expected to post earnings of $2.27 a share - Earnings Preview

Novartis AG

Today 08:32

Novartis AG NOVN.S  is expected to  show a rise in quarterly revenue when it reports  results on October 27 for the period ending September 30 2026
The Basel Basel-stadt-based  company is expected to report a 4.8% increase in revenue to $14.582 billion from $13.91 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data. (Majority Sales represents Net Sales)
​LSEG's mean analyst estimate for Novartis AG is for earnings of $2.27 per share. 
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 10 "strong buy" or "buy," 15 "hold" and 3 "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Novartis AG is CHF128.40, about 0.4% below its last closing price of CHF128.88
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Jun. 30 2026
2.27
2.27
2.41
Beat
6.3
Mar. 31 2026
2.15
2.13
1.99
Missed
-6.7
Dec. 31 2025
1.99
1.99
2.03
Beat
1.8​
Sep. 30 2025
2.27
2.25
2.25
Met
-0.1
​​Jun. 30 2025
2.40
2.36
2.42
Beat
2.6
Mar. 31 2025
2.11
2.10
2.28
Beat
8.7​
Dec. 31 2024
1.82
1.83
1.98
Beat
8.2
Sep. 30 2024
1.95
1.95
2.06
Beat
5.9
This summary was machine generated October 23 at 07:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)